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Lambdoid phages suppress transcription termination to fully express their genes. 
Antitermination of early gene expression in most lambdoid phages is mediated by an 
interaction between the N protein and a number of host-encoded factors. Bacteriophage 
HK022 does not rely on a protein for antitermination. To promote full expression of early 
phage genes, the transcripts of the HK022 put sites interact directly with RNA 
polymerase to convert it to a termination resistant form. Bacteriophage HK639 also uses 
RNA-mediated antitermination. However, it only possesses a single put-like element in 
its left operon. Because most lambdoid phages, including HK022, have antiterminator 
elements in each of their early operons, the presence of a single antitermination site in 
HK639 was unexpected.  
We have shown that host genes involved in promoting protein-mediated 
antitermination are not required for HK639 growth. We have also shown that expression 
of the left operon is essential for lytic growth. Replacement of the left operon promoter, 
PL, and the putL antitermination sequence prevented HK639 phage release. A similar 
construct that only replaced putL also prevented phage release. These results suggest that 
antitermination is required for HK639 excision and/or lytic growth. To distinguish 
between a defect in phage excision versus a defect in lytic growth, the mutations were 
crossed onto lytically growing phage. Recombinant phages could not be recovered which 
suggests a defect in lytic growth is preventing phage release. 
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 Additional replacements of left operon sequences suggest that antitermination is 
not the only requirement for lytic growth.  A 2,161bp deletion (HK639 genome 
coordinates 30,888-33,048) and a 1,736bp deletion (HK639 genome coordinates 29,152-
30,887) downstream of the HK639 putL site also prevented phage release, whereas a 
1,746bp deletion (HK639 genome coordinates 29,151-27,406) did not. These results 
suggest that the deleted HK639 left operon sequences are required for lytic growth. 
BLAST analysis did not provide insight into the function of the deleted genes. Although 
the function of many of the HK639 left operon genes is unknown, their importance in 
phage growth can now be verified by complementation analysis. Our results suggest that 
HK639 may use a novel mechanism to control the expression of its early genes.  
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INTRODUCTION 
Bacteriophages (phages) are viruses that infect bacteria. They are ubiquitous and 
are proposed to be the most abundant entity in the biosphere. Outnumbering their 
bacterial hosts by a factor of ten, the global population of phage particles is estimated to 
be in excess of 1031 (1). Since their discovery in 1915 and 1917 by Frederick Twort and 
Felix d’Herelle respectively, phage have been studied in many laboratories and used in a 
variety of applications (2). The earliest use of phage was to control human disease but, a 
poor understanding of phage biology, coupled with the discovery of antibiotics, lead to 
the downfall of phage therapy (2). Instead, phage made their claim to fame, in the 
laboratory, as one of the most influential research tools in history. Some of the most 
significant contributions to biology can be attributed to work with phage including the 
identification of DNA as the molecule of inheritance, the understanding of the genetic 
code and the development of molecular biology (3, 4). Studies have demonstrated their 
abundance in nature (1), the diversity of their genomes (5), their impact on the carbon 
cycle (6) and their contribution to bacterial evolution (7).  
Phage influence bacterial evolution by applying selective pressures to bacterial 
populations both directly, by killing susceptible bacteria and leaving resistant ones to 
thrive, and indirectly, by increasing bacterial fitness through the trafficking of genomic 
islands (8, 9). The ability of bacteria to adapt to new conditions is most often the result of 
the acquisition of new genes through horizontal gene transfer and other phage-mediated 
recombination events. Phages depend on their host. Therefore, it benefits them to carry 
genetic tools that can increase the fitness of their host (i.e. antibiotic resistance cassettes, 
toxin gene) (10). Bacteria fight back by evolving defense mechanisms. Conceivably, the 
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evolutionary arms race between phage and bacteria has been underway since life began 
making bacteriophages a potentially rich resource for the discovery of candidate 
antibacterial agents. 
Phage protect the delicate balance of our ecosystem by mediating critical 
ecological processes (i.e. nutrient cycling, decomposition) by controlling bacterial 
populations (6). Phage also pose a risk to human health by contributing to the success of 
bacterial pathogens.  The signs and symptoms of many serious bacterial diseases are due 
to toxins which are encoded by bacteriophage (Cholera, Scarlet fever, Diphtheria) (11). 
Phage are useful in the fight against pathogens because they have evolved and continue to 
evolve mechanisms to overcome the defenses of bacteria. Phage constitute one of the 
most expansive collections of novel genes and gene products. These genes and gene 
products have been honed by billions of years of evolutionary competition with bacteria 
to be the perfect weapons against bacteria (12).  
Recently, phage research has focused on genomics and the understanding of 
genetic regulatory mechanisms. The development of the “informed” tools that are needed 
to make an enduring impact in microbial control may benefit from the study of the 
mechanisms that control gene expression (13). Understanding when and how phage use 
their own genetic tools will improve our understanding of their utility in human 
applications.  
Phage Morphology 
Compared to animal or plant viruses, phages have a complex morphology. They 
have a capsid, or head, which encloses their genetic material and many also have tails. 
The genomes of most bacteriophage are double stranded DNA (dsDNA). However, other 
   
3 
  
nucleic acid and strand configurations are possible (i.e. ssDNA, dsRNA and ssRNA). 
Phages have compact genomes that are expressed in a highly regulated manner. Thus, 
bacteriophages provide excellent models for understanding mechanisms of controlling 
gene expression. Temperate phages have been a rich source of information because they 
are capable of switching between two lifestyles: lytic and lysogenic.  
Lytic vs Lysogenic lifestyles 
The lytic cycle is characterized by the lysis of the host cell and release of new 
phage particles at the end of the infection process (Figure 1). Phage infect specific hosts 
by binding to receptors on the host’s surface. The DNA in the head of the phage is 
ejected through the tail and into the cytoplasm of the host. Once in the cytoplasm, the 
genome circularizes and the host transcription machinery begins transcribing early phage 
genes. DNA replication proteins are made and many copies of the phage genome are 
generated. Structural components, such as head and tail proteins, are mass produced. The 
new phage particles self-assemble and the genome is packaged. At the end of the cycle, 
enzymes encoded by the phage degrade the host’s cell wall promoting cell lysis and 
phage release. Phage committed exclusively to this pathway are termed lytic phage (14). 
The alternative lifestyle adopted by temperate phages is called lysogeny (Figure 
1). The entire phage genome physically integrates into the host’s chromosome. The 
integration of the phage takes place at a special attachment site in the host genome. The 
sequence of the bacterial attachment site is called attB and the sequence in the 
circularized phage genome is called attP (Figure 2).  An incorporated phage genome is 
referred to as a prophage and it is copied along with the host chromosome each time the 
host cell replicates. Thus, the prophage is a heritable part of all daughter cells without 
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cycling through the entire infection process. The host cell and all its descendants are said 
to be lysogenic for the infecting phage and the host cell harboring a prophage is called a 
lysogen. A phage-encoded repressor protein maintains this dormant state by silencing the 
expression of all phage genes except for its own. Spontaneous derepression can cause the 
phage to excise itself and enter the lytic cycle.  More often, the prophage is induced to 
enter the lytic cycle in response to DNA damage in the host, (14). 
Two factors, integrase (Int) and excisase (Xis), mediate integration and excision 
of the phage genome. The genes which code for integrase (int) and excisase (xis) are 
among the last to be expressed in the left operon.  The Int protein is expressed from its 
own promoter, PI, which is activated only during a lysogeny event. Though integration 
and excision are complex processes, it is important to note that high levels of Int favor 
integration while equal concentrations of Int and Xis favor excision (14).  
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Figure 1. The lytic and lysogenic lifestyles. The phage genomic DNA is colored red. The 
bacterial (host) chromosome is colored blue.   
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A paradigm for gene regulation: Phage λ 
Phage λ is the best-characterized temperate phage. It was discovered in 1951 by 
Esther Lederberg while she was investigating phenotypic differences between two strains 
of Escherichia coli, one of which had been mutagenized with UV light (15). Dr. 
Lederberg observed a “nibbled on” appearance of the bacterial colonies, which was 
evidence of cell destruction. It was concluded that the UV light had induced a prophage 
to enter the lytic cycle (15). Lambda is one of the first viruses to be understood at the 
molecular level and its study has led to the development of multiple tools and techniques 
used in molecular genetics. Lambda is used as a cloning vector and as a gene delivery 
system (16, 17). It has been a very informative model for the molecular basis of genetic 
recombination (18, 19). Studies on λ led to the discovery of restriction enzymes and, 
eventually, to their use in genetic engineering (20, 21). More recently, studies on λ have 
led to the development of genome engineering techniques that use phage-encoded DNA 
recombination enzymes. One such technique, called Recombineering, is based on the 
λRed system (22). The tools for molecular genetics and the knowledge associated with 
their use have grown in tandem with the understanding of λ biology.  
Lambda and its relatives specifically infect Escherichia coli cells and they all 
have a characteristic gene organization. The early genes of lambdoid phages are 
organized into two divergently transcribed operons (Figure 2). The right operon carries 
genes necessary for genome replication, late gene regulation (the Q antitermination 
protein), phage morphogenesis and host cell lysis. The left operon carries the early gene 
regulator (the N antitermination protein), as well as the DNA replication and 
recombination proteins. The expression of all phage genes is tightly regulated. 
  
 
 
Figure 2. The bacteriophage 
form. The arrows indicate the 
dashed lines represent operons. The blue (left operon) and red (right operon) arrows show 
early genes that are regula
are regulated by the Q protein.  The 
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λ genome. The λ genome is represented in its 
direction of transcription from the major promoters. The 
ted by the N protein.  The green arrow shows late genes that 
attP site is labeled within the circle. 
circularized 
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Transcription elongation and control 
Transcription is the first step in gene expression. As with all viruses, phages rely 
on the transcription machinery of their host. During transcription of most bacteriophages, 
DNA serves as a template for the production of messenger RNA (mRNA). The 
“message” is subsequently translated into a sequence of amino acids that ultimately folds 
into a biologically active protein. Transcription occurs in three stages: initiation, 
elongation and termination (14). Initiation occurs at specific DNA sequences called 
promoters. Promoters are located at the beginning of genes and are responsible for 
directing RNA polymerase (RNAP) to begin the process of synthesizing RNA. Host-
encoded bacterial transcription initiation proteins, known as sigma factors, enable RNAP 
to specifically bind to a promoter (23). Elongation refers to the growing strand of mRNA 
created by RNAP after each successive nucleotide addition. RNAP continues to copy the 
DNA for long distances until its progress is interrupted by transcription terminators 
which cause the transcription complex to dissociate. 
In bacteria, transcription termination signals are grouped into two classes: 
intrinsic and factor-dependent terminators (24, 25). Intrinsic terminators are composed of 
a GC-rich RNA hairpin followed by a run of U residues. Termination at an intrinsic 
terminator occurs in two steps. First, RNAP pauses within the U track and then the 
interaction between the hairpin and RNAP causes the RNA to be released. No protein 
factors are required for this to occur, however, certain accessory proteins such as NusA 
can enhance recognition of intrinsic termination signals by the elongation complex (26). 
Intrinsic termination signals are common in E. coli and their characteristic features can 
easily be identified by computational analysis.  
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In contrast to intrinsic terminators, factor-dependent terminators rely on the 
interaction of regulatory proteins. One such factor is Rho, found in many prokaryotes. 
Rho is an ATP-dependent translocase. It recognizes and binds to a specific sequence in 
mRNA called the Rho utilization site or rut and uses the energy of ATP hydrolysis to 
move along the transcript in a 3’ direction until it encounters RNAP (27). Rho can then 
stop transcription by using its helicase activity to unwind the RNA-DNA hybrid (28, 29).  
Regulatory mechanisms have been identified at virtually every stage of 
transcription, including termination (30). In fact, some viruses have evolved the ability to 
override transcription termination signals. This mechanism is known as antitermination 
(24). Transcription antiterminators modify RNAP and convert it into a terminator 
resistant form. This allows the expression of genes downstream of terminator sites. 
Transcription terminators are located throughout lambdoid phage genomes and 
antitermination is necessary for the full expression of phage genes (31). Persistent 
antitermination, defined as readthrough of multiple sequential termination signals, was 
originally discovered in phage λ (32). In λ, the transition between the expression of early 
genes to those required at later stages of infection depends on the readthrough of 
termination signals. Antitermination of the λ early genes is mediated by a phage-encoded 
factor called N (33). The late genes are antiterminated by a different antiterminator, the Q 
protein. The Q protein, acting through a different mechanism, converts RNAP into a 
termination resistant form and promotes the readthrough of termination signals in the late 
gene operon.  
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Antitermination of early gene transcripts in phage λ 
To suppress termination of early gene transcription originating from the early 
gene promoters, PL and PR, the N protein binds as a dimer to a stem-loop structure in the 
nascent nut RNA transcripts (34).  There is a copy of the nut site in each operon.  
The association of N and RNAP is stabilized by a network of weak protein-protein and 
protein-RNA interactions. The host-encoded Nus factors, NusA, B, E and G, assemble to 
form an elongation complex (31). The name “Nus” stands for N-utilization substance 
(35). Through RNA looping, the N-nut complex binds RNAP through the NusA adapter 
protein (Figure 3) (34). NusG also interacts directly with RNAP to stablize the elongation 
complex (36).  
The RNAP-N-Nus complex, once assembled, is resistant to sequential 
downstream termination signals. This type of persistent antitermination is said to be 
factor-dependent because readthrough of termination signals depends on the action of a 
protein factor (37). The N antiterminator protein is the first gene to be expressed in the 
left operon of λ. The nutL sequence is located between the N gene and the promoter. In 
the right operon, nutR is located immediately downstream of cro thus making the 
expression of N, in the left operon, necessary for antitermination to occur in the right 
operon. 
 
 
 
 
 
  
 
 
Figure 3. Current model of N 
the interaction between RNA polymeras
the host-encoded factors that
during transcription (gray ovals)
continues through the nut
within the mRNA transcript 
the complex is stable and terminator resistant. The stop sign
terminator. Adapted (31).
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-mediated antitermination. This simplified diagram shows 
e (purple), the N protein dimer (blue 
 convert RNA polymerase into a terminator resistant form 
. Transcription begins at the promoter, labeled “P,” and 
 site (blue) and N gene (white box). The nut sequence 
folds into the stem-loop structure (orange). Once assembled, 
 represents a 
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embedded 
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The antiterminator RNAs of bacteriophage HK022   
Bacteriophage HK022 is a member of the lambdoid family and also uses 
processive antitermination to regulate the expression of its early genes. However, it does 
not produce an analog of the λ N protein (38, 39). In contrast to phage λ, antitermination 
in HK022 is factor-independent. Terminator readthrough is promoted by the direct 
interaction of the nascent RNA transcript with RNAP (40, 41). The transcripts of the put 
(polymerization utilization) sites fold into a highly organized, dual stem-loop structure 
that converts RNAP into a terminator resistant form (Figure 4) (39, 40). A put site is 
located in each early operon of HK022. Mutations that occur in the zinc binding domain 
of the β’ subunit of RNAP block the interaction between put and RNA polymerase and 
prevent the growth of HK022 (42). One such mutant, rpoCY75N, has been useful in 
identifying additional bacteriophage that use antiterminator RNAs (43). RNA-mediated 
transcription antitermination challenges the protein mediated mechanism found in the 
well-established λ paradigm (40).  
The put RNA transcripts are a unique example of a regulatory RNA. 
Traditionally, RNA has been thought to only participate in post-transcriptional gene 
expression events such as protein synthesis. During protein synthesis, messenger RNA 
(mRNA) serves as a template for the assembly of proteins on ribosomes. Transfer RNAs 
(tRNA) transport amino acids to the ribosome where ribosomal RNAs (rRNA) catalyze 
peptide bond formation to link amino acids together to form proteins. While the role of 
RNA in translation is well established, RNA is now known to play other critical roles in 
the cell (44, 45). Research efforts are now actively being focused on understanding the 
roles RNAs play in controlling gene expression (46, 47). A large number of 
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riboregulators have been identified. Of these, microRNAs (miRNAs) and small 
interfering RNAs (siRNAs) are the best characterized. miRNAs are short sequences of 
RNA that function as gene silencers by binding to mRNA transcripts through 
complementary base pairing and blocking the progress of translating ribosomes (47). This 
interference results in the premature degradation of the transcript. The siRNAs have a 
similar function. The distinction between the two small RNA molecules derives from 
their ability to silence their own expression. Most siRNAs silence the loci from which 
they were transcribed while miRNAs silence genes from other loci (48).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 4. Current model of 
mediated by an interaction between the nascent mRNA transcript
RNA polymerase initiates transcription at the promoter (black arrow). The 
is transcribed and the mRNA folds into a stem
transcript interacts with the 
terminator resistant form allowing read
Adapted (49). 
 
 
 
 
 
 
 
 
 
 
  
14 
 
put-mediated antitermination. Antitermination in HK022 is 
 and RNA polymerase. 
-loop structure (orange). The nascent 
β’ subunit of RNAP and converts the enzyme into a 
-through downstream terminators (
put site (blue) 
stop sign). 
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The antitermination mechanism of bacteriophage HK639 
Bacteriophage HK639 was discovered because it cannot grow on the rpoCY75N 
mutant. This mutation blocks the interaction between RNAP and the put transcript (42). 
This result suggested that it may also use RNA-mediated antitermination.  It is a 
temperate phage and its genome has been completely sequenced (43). Overall, its genetic 
organization broadly resembles phage λ and other members of the lambdoid family 
(Figure5). A closer look, however, reveals intriguing differences in regards to its 
regulation of early gene expression. A put-like sequence in the left operon of HK639 was 
identified and it was shown that this site promotes antitermination by interacting with 
RNA polymerase in a manner similar to the HK022 put sites (43) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 5. Maps of lambdoid phage early genes. Transcription of the
the promoters, PL and PR 
indicated with boxes. Those known to be involved with antitermination are shaded blue. 
Transcription terminator(s) are represented with stop signs. 
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 early genes begins at 
(black arrows). Genes and key regulatory sequences are 
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Unlike the left operon, a put-like sequence could not be identified in the right 
operon of HK639 using BLAST (43). To determine if a structural homolog of put was 
present in the right operon, the RNA folding program, Mfold (50), was used to fold 
untranslated regions of the right operon transcript (43).  No structures analogous to the 
HK022 putL or putR sites were identified (43). In addition, there are no sequences that 
have statistically significant similarity to known nut sites or to known N-like proteins.  
To determine if HK639 right operon transcription is antiterminated by factor-
independent RNA-mediated antitermination, a segment of the early right operon 
sequence which included cro, cII, and the intergenic regions between cII and the initial 
portion of orf38 was fused upstream of Tr’T1T2 in a reporter construct (43). Similar 
fusions were made without the terminator set. Reporter assays revealed no readthrough of 
the terminator cluster. It was concluded that no put-like antiterminator RNA was present 
in the selected early region of the HK639 genome (43).  
The lack of an antiterminator in the right operon of HK639 was unexpected.  It 
was hypothesized that perhaps antitermination is not necessary for the expression of right 
operon genes. However, a computer aided search revealed a single Rho-independent 
terminator in the early right operon. The presence of this terminator suggests that it must 
be suppressed so that downstream genes can be fully expressed. Rho-dependent 
terminators are difficult to identify by computer analysis. Consequently, no information 
is available on the presence and/or location of Rho-dependent terminators in the HK639 
genome (43).  
To test for the presence of an antitermination mechanism in the right operon, 
recombineering was used to insert a set of 3 strong terminators at different locations in an 
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HK639 prophage (Tr’T1T2-glyT-kan) fusion (Figure 6) (43). Controls were constructed 
by recombining a fusion without terminators (glyT-kan) into the same genomic locations. 
Fusions with or without terminators made in or near the M3 region were unable to release 
phage. This result suggests that an essential function was disrupted by these fusions. The 
function of the M3 region is currently unknown. Two fusions that were made further 
downstream of M3 were able to release phage (43). These results suggest that 
antitermination does occur in the right operon of HK639. (43).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 6. Map of terminator fusions
approximate locations at which fusions were made
unable to release phage. G
Terminators are labeled with red arrows. 
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 in right operon of HK639. The boxes
. Red indicates fusions that were 
reen indicates fusions which were able to release phage. 
         
 
 indicate the 
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The goal of my research was to better understand early gene expression of 
lambdoid phage by comparing and contrasting the newly discovered bacteriophage 
HK639 with the mechanisms characterized in bacteriophages λ and HK022. Phage 
HK639 does not appear to have any of the known antitermination elements in its right 
operon. However, our evidence suggests that antitermination does occur in both early 
operons. To determine if host-encoded factors essential for protein-mediated 
antitermination are required for antitermination in HK639, host strains carrying precise 
deletions of the nusA or nusG genes, were infected with HK639 and the growth of the 
phage on each mutant was compared to the growth on wild-type strains.  
In HK022, there are no genes in the left operon that are required for lytic growth. 
To determine if the same is true for HK639, we deleted the left operon promoter and putL 
antitermination sequences from an HK639 prophage. Additional replacements of left 
operon sequences suggest that antitermination is not the only requirement for phage 
growth. It was expected that these studies would provide insight into how HK639 
controls the expression of its early genes. Additionally, it was expected that this work 
would reveal valuable information regarding the biology of this newly discovered 
bacteriophage. 
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MATERIALS & METHODS 
Bacterial strains, plasmids and bacteriophages   
Bacterial strains, plasmids and bacteriophages used in this study are listed in 
Table 1.  
Media 
The recipes for bacteriological media used in this study are as follows: Luria 
Bertani (LB) broth (per liter): 10 g Tryptone, 5 g yeast extract, 5 g NaCl. Typtone (TB) 
broth (per liter): 10 g Tryptone, 5 g NaCl, pH to 7.4. LB plates (per liter): 10 g Tryptone, 
5 g yeast extract, 5 g NaCl, 15 g agar. TB top agar (per liter): 10 g Tryptone, 5 g NaCl, 7 
g agar, pH to 7.0. SOC (per liter): 20 g Tryptone, 5 g yeast extract, 0.5 g NaCl, 1.25 ml of 
2M KCl, 5 ml 1M MgCl2, 1 ml 1M MgSO4, 2 ml 1M glucose. TMG (per liter): 10 ml 1M 
Tris base, 10 ml 1M MgSO4, 100 mg gelatin, adjusted to pH 7.4 with HCl.  50X TAE 
(per liter): 242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 0.5M EDTA. 
Overnight cultures 
Cells were grown in 5 ml overnight culture at 37°C in TB or LB broth with 
shaking at 220 rpm unless otherwise noted. Antibiotics were added (when required) at the 
following concentrations: ampicillin (100 µg/ml; 25 µg/ml for screening recombineering 
candidates), kanamycin (20 µg/ml). Following overnight incubation, cells were harvested 
by centrifuging at 2,750 x g for 10 minutes. The resulting cell pellet was suspended in 
half the volume of 10 mM MgSO4 and stored at 4°C.  
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Table 1. Bacterial strains, plasmids and bacteriophage  
Strains Relevant genotype or characteristics Reference 
MC1000 ∆(lac)X74 51 
RK1097 
MG1655(HK022 @ tRNAgly at 10Kb) 
rpoC+/pLUXam; SB1424/pSB1326; ampR, camR, 
kanR 
52 
RK1145 MC1000 (HK639) transformed with pRK1006; ampR King, R. 
RK1275 RSW414 = MDS42 tonA- reduced genome 53 
RK1276 RSW421 = MDS42 ∆nusA::camR 53 
RK1277 RSW422 = MDS42 ∆nusG::kanR 53 
RK1278 RSW472 = MG1655 ∆rac::camR 53  
RK1279 RSW481 =MG1655 ∆rac::camR; ∆nusG::kanR 53 
RK1288 RK1145 ∆PL-putL::kanR This work 
RK1319 RK1145 ∆putL::kanR This work 
RK1321 MC1000;  pBR322/PL-putL::kanR This work 
RK1328 RK1145 ∆30,888-33,048::kanR This work 
RK1329 RK1145 ∆29,152-30,887::kanR This work 
RK1330 RK1145 ∆27,406-29,151::kanR This work 
RK1331 MC1000;  pBR322/putL::kanR This work 
RK1332 RK1145 ∆26,022-27,406-::kanR This work 
RK898 RW4198  = MG1655; wild-type, rpoC+ Weisberg, R. unpublished 
RK899 RW4200 = MG1655; rpoCY75N Weisberg, R. unpublished 
Plasmids 
  
pBR322 Cloning vector in E. coli; ampR, tetR NEB Cat. No. N3033S 
pRK1006 pSim6 [= ori-pSC101repA(ts) (cI857 PL-exo-bet-gam; 
ampR)] 22 
pRK1321 pBR322 with PL-putL::kanR This work 
pRK1331 pBR322 with putL::kanR This work 
Phage   
HK639  54 
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Microfiltration 
Microfiltration was performed using Amicon Ultra 0.5 Centrifugal Filter Devices 
(Fisher Cat. No. UFC510096). Sterile npH2O, 500 µl minus the sample volume, was 
pipetted into the filtration device. Nanopure water (npH2O) is high purity deionized water 
made from a Barnstead Nanopure Infinity Ultrapure water system. The sample was added 
to the water and mixed well. To remove salts, the sample, was centrifuged at 10,000 x g 
for 10 minutes at room temperature. The sample was washed 3X by adding 500µl of 
sterile npH2O and centrifuging at the settings previously described. The flowthrough 
volume was discarded after each centrifugation.  The purified sample was collected by 
inverting the filtration device and centrifuging at 1,000 x g for 2 minutes. The typical 
volume recovered was ~20 µl. 
Polymerase Chain Reaction 
Taq polymerase (Fisher Cat. No. FB-6000-15) was used to amplify products of 
less than 1000 bp. The thermocycler settings for reactions in which Taq polymerase was 
used were as follows: 95°C for 1 min, 34 cycles of 95°C for 1 min, 55°C for 1 min, 72°C 
for 2min, then 72°C for 10 min followed by a 4°C hold. 
Phusion High Fidelity PCR Kit (NEB Cat. No. E0553L) contains a high fidelity 
polymerase that creates products with blunted ends and has an error rate that is estimated 
to be >50 fold lower than that of Taq polymerase. This enzyme was used where high 
fidelity was required (i.e. amplification of the kanamycin resistance gene). The 
thermocycler settings were as follows: 98°C for 30s, 34 cycles of 98°C for 10s, 52°C for 
30s, 72°C for 2 min, then 72°C for 10 min followed by a 4°C hold. A list of 
oligonucleotides used in this work can be found in Table 2 and Table 3.  
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Table 2. Oligonucleotides used for PCR 
Name Sequence Use/Special Features 
RK192 CTCGAAACGAATAGCATTTAC To confirm upstream junction, strain 
RK1332 
RK227 TCAGGAATTCCCTGAAAGGAAC To confirm downstream junction, strain 
RK1319 
RK232 GGAATTTCTCTTCCAATGAAC To confirm upstream junction, strain 
RK1288 
RK277 CTGTTTTTGTGAGCATAGCAC To confirm upstream junction, strain 
RK1319 
RK290 TTGCCATGTTTCAGAAACAACTC Primes within kanR, forward 
RK291 GATCTTGCCATCCTATGGAAC Primes within kanR, reverse 
RK299 CACGCTTCAGCCTTCAGCTTGT To confirm downstream junction, strain 
RK1330 
RK570 CGCGGCAAGCCAAAATATAG To confirm upstream junction, strain 
RK1328 
RK659 CCCGATGATTTTGACTTTGAG To confirm downstream junction, strain 
RK1288 
RK710 TCACGGATCCGTTTTTTTATCTGC
CATACAC 
    
To amplify kanR from RK1288 & RK1319; 
BamHI site is underlined 
 
RK711 TCAGAAGCTTTGTGAGCATAGCA
CTCATG 
 
To amplify kanR from RK1288; HindIII site 
is underlined  
 
RK734 CTCTGCAAGACGCTTGCTTTC  To confirm downstream junction, strain 
RK1328 
RK735  GCGAAGTACTGCCTCTTTCC  To confirm downstream junction, strain 
RK1329 
RK736 CCATCCAGTCACTATGTGAGG  To confirm upstream junction, strain 
RK1329 
RK737 GGTTCGCCACCGTCTTGAGTTG  To confirm upstream junction, strain 
RK1330 
RK738 TCAGAAGCTTTAATCCATCGAAA
CGAAACATC   
 
To amplify kanR from RK1319; HindIII site 
is underlined  
 
RK742 GATGTGTCATGCATTAATGAGC To confirm downstream junction, strain 
RK1332 
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DNA gel electrophoresis 
Gel electrophoresis was performed using Fisher brand electrophoresis systems 
(Fisher Cat. No. FB-SB-710 or FB-SB R-1316). Two percent agarose gels were used to 
identify DNA molecules that were less than 1000 bp in length and 1.3% gels were used to 
identify bands greater than 1000 bp in length. DNA size standards used included 100 bp 
ladder (Axygen Cat.No. M-DNA-100BP), 1Kb ladder (Fisher Cat. No. BP2578100), 2 
Kb ladder (Fisher Cat. No. BP2578100) and λ DNA /Hind III (Fisher Cat. No. PR-
G1711). Gels were run in 1XTAE buffer. The voltage settings are 10 v/cm for 60 minutes 
(FB-SB-7100 and 6 v/cm for 90 minutes (FB-SB R-1316).  
Restriction digests 
Restriction enzymes used in this study include: BamHI (NEB Cat. No. R0104S) 
and HindIII (NEB Cat. No. R0136S). A typical digestion reaction contained 20 µl of 
DNA, 2 µl of restriction enzyme, (BamHI digestions were supplemented with BSA to 
final concentration of 1X), 5 µl of appropriate 10X buffer, and npH2O to 50 µl total 
volume. Restriction digest reactions were incubated at the recommended time and 
temperature. For sequential digestions, HindIII (a heat labile enzyme) was heat 
inactivated by incubating at 65°C for 20 minutes. Buffer exchanges, when necessary, 
were performed using microfiltration as previously described.  
Extractions of DNA fragments from agarose gels 
For purifying desired DNA fragments, 2 µl of loading dye per 5 µl of restriction 
digest was added to the restriction digest sample. The sample was divided into 10 equal 
volumes and distributed evenly among the wells of an agarose gel (12 µl/well). Gels were 
stained for at least 10 minutes in 1X TAE buffer that contained 0.5 µg/ml ethidium 
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bromide. To visualize the DNA fragments, the gel was placed on a UV light table and the 
desired region was removed from the gel with a razor blade. The agarose strip was 
divided into equal halves and placed into sterile microfuge tubes where it was sliced into 
smaller fragments using an 18 gauge needle. The DNA was extracted from the gel matrix 
using the phenol-freeze method (55). The samples were vortexed then frozen at -80°C for 
15 minutes. Frozen samples were then centrifuged and the aqueous solution was 
extracted using a pipette. This solution was separated into equal volumes. To remove all 
traces of phenol, twice the volume of chloroform was added to each tube. After briefly 
vortexing the samples, they were centrifuged to separate the aqueous and organic layers.  
The aqueous layer was removed and chloroform extraction was repeated once.  The DNA 
was recovered from the aqueous layer using ethanol precipitation.  
Ethanol precipitation 
 Following gel extraction, a 1/10 volume of sterile 3M Na(C2H3O2)2 , pH 5.2 was 
added to samples containing DNA followed by 2X the volume of 100% cold ethanol. 
Samples were chilled at -20°C for 20 minutes and then centrifuged at 17,200 x g for 25 
minutes at 4ºC. The supernatant was decanted and the pellets containing the DNA were 
allowed to air dry by inverting the microfuge tubes on a paper towel. In cases where the 
same DNA sample had been distributed among multiple tubes, one of the DNA pellets 
was suspended in 50 µl of elution buffer (10 mM Tris-Cl, pH 8.5) and this solution was 
then transferred to the other sample tubes until all the DNA pellets were dissolved in the 
same volume of buffer. In lieu of a wash with 70% ethanol, these samples were purified 
using microfiltration as described above.  
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Ligations 
Ligations were performed using T4 Ligase (NEB Catalog No. M0202S). A typical 
ligation reaction consisted of insert, vector, 2 µl of ligase buffer, 1µl of ligase and npH2O 
to 20 µl total volume. The volume of insert and vector were determined on a case by case 
basis depending upon their concentrations as visualized by gel electrophoresis. An 
attempt was made to include approximately twice the amount of insert as vector. A no 
insert control was included with each ligation reaction. Ligation reactions were incubated 
overnight at 14°C. The next day, the T4 Ligase was heat inactivated by incubating the 
reaction at 65°C for 20 minutes. 
Preparation of electrocompetent cells  
Overnight cultures were diluted 1:100 in LB broth in two separate 5ml aliquots 
and grown at 37ºC with shaking at 220 rpm. At an O.D.650 of 0.4, the cultures were 
centrifuged at 2,750 x g for 10 minutes at 4ºC. The supernatant was discarded and the 
pellet was resuspended in ice cold 10% glycerol using a serological pipette. The cells 
were pelleted by centrifugation.  The cells were subjected to two additional washes with 
ice cold 10% glycerol. After the third wash, the pelleted cells were resuspended in 1.5 ml 
of ice cold 10% glycerol transferred to a cold microcentrifuge tube and centrifuged at 
3,500 x g for 10 minutes.  The supernatant was decanted and the pellet was resuspended 
in the volume of supernatant remaining in the tube (~50 µl). The electrocompetent cells 
were always used immediately. 
For preparing electrocompetent cells for recombineering experiments, overnight 
cultures of the recombineering strain, RK1145, were diluted 1:100 in LB broth 
supplemented with ampicillin (20 µg/ml) in two separate 25 ml aliquots and grown at 
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30ºC with shaking at 220 rpm. At an O.D.650 of 0.3 to 0.4 one flask was put in a 42ºC 
water bath, and incubated, for 15 minutes with shaking at 220 rpm. Incubation of the 
other flask was continued at 30ºC; this culture served as the uninduced control. Next, 
both flasks were rapidly chilled in an ice water bath and were kept cold for the remainder 
of the procedure. Samples from each culture (12.5 ml) were transferred to two 15 ml pre-
chilled conical tubes. From this point on, cultures were treated as outlined above.   
Electroporation 
All DNA samples and electrocompetent cells were kept on ice throughout this 
procedure. DNA was added to 50 µl of freshly prepared electrocompetent cells at         
100 ng/µl (not to exceed 10 µl in total volume) or 2 µl of plasmid prep. Cells were 
transferred by pipette to pre-chilled 2 mm electroporation cuvettes (Fisher Cat. No. 
FB102). Electroporation was performed using the Bio-Rad Gene Pulser xCell at 2.5 kV, 
25 µf, 200ohm. Time constants were typically 5.1 milliseconds. For plasmid 
electroporations, the cells were resuspended in 1ml of SOC and transferred to 15 ml 
cultures tubes. The electroporated cells were incubated at 37°C with shaking at 220 rpm 
for 1 hr. Cells (100 µl) were plated on LB supplemented with kanamycin (20 µg/ml) and 
incubated at 37°. The next day, transformants were streaked for isolation on LB plates 
supplemented with kanamycin (20 µg/ml). After obtaining purified colonies, overnight 
cultures were prepared and processed as outlined above. Cultures were suspended in 10 
mM MgSO4 and stored at 4ºC for further testing. For recombineering electroporations, 
the cells were treated as described below (see “Recombineering”) 
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Plasmid isolation 
Cells were grown in 5 ml overnight culture in LB broth supplemented with the 
appropriate antibiotic. Cells were harvested by centrifuging at 2,750 x g for 10 minutes at 
4ºC. Plasmid isolations were performed using the QIAprep Spin Miniprep Kit (Qiagen, 
Catalog No. 27104) or QIAfilter Plasmid Purification Midi Kit (Qiagen, Catalog No. 
12243) according to the instructions provided by the manufacturer.  
Plaque assays 
To determine the titer of HK639 on ∆nus mutants a serial dilution (10-0 -10-9) of 
phage lysate was prepared in TMG buffer. A 10µl aliquot of each dilution was added to 
50 µl of an overnight culture of susceptible host cells in 5 ml culture tubes (Fisher Cat. 
No. 14-959-11A). The mixture was incubated at room temperature for 20 minutes to 
allow time for phage attachment to occur. Four milliliters of molten (55 °C) TB top agar 
supplemented with MgSO4 at10 mM final concentration was added to the cell/phage 
mixture. The culture tubes were mixed by inversion and the solution was poured over 
pre-warmed LB plates. After the top agar had solidified, the plates were inverted and 
incubated overnight at 37°C. The following day, titers were determined by counting the 
plaques; a plaque is a clear zone on a plate otherwise covered with an opaque lawn of 
bacterial cells. To calculate the titer, the dilution which showed 30-300 individual 
plaques was identified. The plaque forming units, or PFU, was divided by the volume of 
sample plated and then multiplied by the reciprocal of the dilution to obtain the titer in 
PFU/mL. 
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Recombineering 
Strain RK1145 was grown in a 5ml overnight culture at 30°C in TB broth 
supplemented with ampicillin (20 µg/ml). Following overnight incubation, 
electrocompetent cells were prepared as outlined above. The recombineering substrate (a 
PCR amplified DNA), was added at 100 ng. No DNA was added to the control culture. 
The DNA and cell mixtures were added to pre-chilled 2mm electroporation cuvettes. 
Cells were electroporated as outlined above. The cells were resuspended in 1ml of SOC 
and transferred to 15 ml cultures tubes. The electroporated cells were incubated at 30°C 
with shaking at 220 rpm for 2 hrs. Cells were concentrated by centrifugation and 
resuspended in 300 µl of LB broth. Cells (100 µl) were plated on LB broth supplemented 
with kanamycin (20 µg/ml) and incubated at 30°C. The next day, transformants were 
streaked for isolation on LB plates supplemented with kanamycin (20 µg/ml). After 
obtaining purified colonies, overnight cultures were prepared and processed as outlined 
above. Cultures were suspended in 10 mM MgSO4 and stored at 4ºC for further testing. A 
list of recombineering oligonucleotides is provided in Table 3.    
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Table 3. Recombineering oligonucleotides list 
Name Sequence 
RK654 GAGCATAGCACTCATGATTTACAAAAATAAATTCATTTAGTTATCAT
TAATTTATAACTTATGTGATTGtccgacaaccgatgaaagc   
RK655 GTTTTTTTATCTGCCATACACACCCCTCTGTTTGTTTACCGTCAGCCC
CTCGCAAAGAGCTGCTGGTAAATCGgtggaccagttggtga 
RK706 ATAGCTGAGGGAAGTTAGCCAGCGGCGAAGTGGAGATTCGGTCAGT
CGAAtccgacaaccgatgaaagc 
RK707 TGTTTGTTTACCGTCAGCCCCTCGCAAAGAGCTGCTGGTAAATCGTT
TAGgtggaccagttggtgattttg 
RK726 TACGCGCGGCCACACCCGACGGCCCGCAGTTTTATAAAACAATGTCA
TAGtccgacaaccgatgaaagc 
RK727 TAGGTCGTAGGTTCGAATCCTACAGGGCGTGCCATTTAAAAACAGTC
GCTgtggaccagttggtgattttg 
RK728 AAGCGCAGAAGTCTTGTTTAACGTTCGGCGGCGCGGCCTTAAGCGCG
GAGtccgacaaccgatgaaagc 
RK729 GAATCAGTCAGCTTTGCGAAATCATTGGCGATCTGGTAAAGAGCTGT
CATgtggaccagttggtgattttg 
RK730 AGGCCGTCTATGCCAAGTGCAAAGCAAAATTCGAAGAGGTTACGCA
ATGAtccgacaaccgatgaaagc 
RK731 AAACGCCAGCAAATGCAGGGGCCGCATTAGCGACCCGGTGATTTGT
GCTGgtggaccagttggtgattttg 
RK732 AGTTGCTGCCAGGATGCGCGATCGACGTGATCAAAACGGAGGCCGC
ATGAtccgacaaccgatgaaagc 
RK733 TTTCGCTGCCTTTTGCGCAGTGAGTGGCTCTGCTGTAACCATCTCCCC
TCgtggaccagttggtgattttg 
Sequences in lowercase represent regions with homology to the kanamycin resistance 
gene located in strain RK1097. Sequences in uppercase represent regions with homology 
to the target region. 
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Sequencing 
Sequencing reactions were prepared using the BigDye Terminator v3.1 Cycle 
Sequencing Kit (ABI, Catalog No. 4337457). Each reaction contained 2 µl sequencing 
juice, 2 µl BigDye Terminator buffer, 1 µl primer, at least 50 ng of DNA (up to 5 µl) and 
npH2O to 10 µl total volume. The thermocycler settings were as follows: 25 cycles of 
96°C for 30s, 50°C for 15s, 60°C for 4 minutes followed by a 10°C hold. Reactions were 
cleaned-up using SigmaSpin Sequencing Reaction Clean-Up kit (Sigma Catalog No. 
S5059). The samples were dried using a centrivap and the pellets were suspended in 20 µl 
of formamide. Sequences were run on an ABI 3130 sequencer.  
Phage release assays 
To determine the effects of mutations on phage viability, lysogenic strains made 
in this study (Table 2) were tested for spontaneous and induced phage release. One 
milliliter of overnight culture, grown in TB broth supplemented with kanamycin (20 
µg/ml), was transferred to each of two sterile microfuge tubes. One tube of culture was 
treated with 100 µl of chloroform while the other tube was left untreated. After vortexing, 
the cells were pelleted and the lysate was transferred to a sterile microfuge tube. The 
lysates (5 µl) from lysogenic strains were spotted onto a lawn of susceptible host cells 
(MC1000). These lawns were prepared by adding 50 µl of an overnight culture of host 
cells, to 4 ml of molten TB top agar in 5ml culture tubes (Fisher Cat. No14-959-11A). 
After inverting to mix, the solution was poured onto a pre-warmed LB plate and allowed 
to solidify. Plates were inverted and incubated overnight at 37°C.  
To determine if the lysogenic strains were capable of releasing phage particles 
after induction, 250 µl of overnight culture was inoculated into 5 ml of LB broth 
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supplemented with kanamycin (20 µg/ml) and grown to an O.D.650 of 0.1. Mitomycin C 
was added to a final concentration of 2 µg/ml. After incubating for 5 hours, at 30°C with 
shaking at 220 rpm, the mitomycin C treated cultures were processed as described above. 
The mitomycin C induced lysate was then plated as described above. 
Phage infection 
 To cross the ∆PL-putL::kanR and ∆putL:: kanR deletion onto a lytically growing 
phage, strains RK1321 and RK1331 were infected with wild type HK639. Overnight 
cultures of RK1321 and RK1331, were grown in TB broth supplemented with kanamycin 
(20 µg/ml) and harvested as mentioned above. Fifty microliters of each culture was added 
to each of five sterile microfuge tubes. Plaques of wild type HK639 grown on MC1000 
were harvested from a plaque assay plate using a Pasteur pipette. Infections were 
performed by adding an increasing number of plaques to each culture-containing 
microfuge tube; up to four plaques. An uninfected aliquot of each culture served as a 
control. Aliquots (2 ml) of LB broth supplemented with ampicillin (20 µg/ml - 10 mM 
MgSO4), were placed in each of ten 15 ml conical tubes.  Five of the aliquots were 
supplemented with mitomycin C-(2 µg/ml final concentration). After incubating the cells 
for 20 minutes at 25ºC, the entire volume of each phage + cell mixture was transferred to 
the LB broth in the 15 ml culture tubes. After a 6 hour incubation at 37ºC with shaking at 
220 rpm, a lysate was prepared from each sample. To lyse the cells, 100 µl of chloroform 
was added to each culture. Samples were vortexed to ensure adequate mixing. One 
milliliter of each sample was transferred to a sterile microfuge tube, centrifuged at 12,100 
x g for 10 minutes, at room temperature. Seven hundred fifty microliters of each sample 
was removed by pipette and syringe filtered through a 0.22µm filter (Fisher Cat. No. 09 -
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719G). Lysates were stored at 4ºC. The presence of recombinant phage was tested by 
PCR analysis using primer set RK227 x RK291.  
One plaque lysate  
 Plaques from phage infections of RK1321 and RK1331 lysates were picked using 
a Pasteur pipette and suspended in 100 µl of TMG. Following 2 hours of incubation at 
room temp, lysates were analyzed directly by PCR for the presence of recombinant phage 
using primer set RK227 x RK291. 
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RESULTS 
 
Effect of host mutations on HK639 growth 
Bacteriophage λ and its relatives are dependent on host-encoded factors to 
promote antitermination. The importance of these functions was discovered by isolating 
host mutations that prevented phage growth. HK022 uses RNA-mediated antitermination 
to promote full expression of phage genes. It has an antiterminator sequence, the put site, 
in each of its early operons and it does not rely on host-encoded factors for growth. A put 
like sequence was identified in the early left operon of HK639 but no sequence 
resembling a put site was identified in the right operon. Because of the absence of an 
antiterminator RNA in the right operon, it was hypothesized that host-encoded factors 
may be necessary for antitermination of HK639 right operon transcription.  
To test this hypothesis, we determined the ability of HK639 to grow on cells that 
carry deletions in genes known to influence transcription elongation and termination; 
nusA and nusG. Plaque assays, scoring plates for plaque formation, were performed on 
each of the ∆nus mutants. The plaques were counted to obtain titers, which were used to 
calculate the efficiency of plating (EOP). The average EOP values of three separate trials 
are reported in Table 4. 
Our results show that the nusA deletion strain, RK1276, had an EOP value of 
0.14.  This suggests that the deletion reduced the growth of HK639 by 86% when 
compared to the wild type control, RK1275. The EOP on a strain known to block HK639 
growth, strain RK899 (rpoCY75N), was <10-7.  When compared to the rpoCY75N 
mutation, the effect of the nusA deletion is relatively minor. Since we additionally 
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observed a growth defect for the strain carrying the nusA deletion, we suggest that this 
defect strongly impacted the observed EOP (see Discussion).   
Our results show that strains RK1277, RK1278 and strain RK1279 have EOP 
values of 0.59, 1.66 and 1.07, respectively. These results suggest that the deletion of only 
nusG (RK1277) reduces growth of HK639 by 49% when compared to the wild type 
control, RK1275. The rac and rac+nusG deletions do not negatively affect HK639 
growth. Similar to nusA mutant, the nusG mutant has a strong growth defect associated 
with the deletion of only nusG and we suggest this impacted the observed EOP (See 
Discussion).  
Based on these results, we conclude that it is unlikely that NusA or NusG play a 
primary role in the growth of bacteriophage HK639. This result suggests that a 
mechanism similar to the host factor-dependent antitermination in lambda is not involved 
in regulation of gene expression in HK639. 
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Table 4. Efficiency of plating assays 
Strain Titers (PFU/ml) Avg. Titer EOP 
value* 
 Trial 1 Trial 2 Trial 3   
RK1275 1.56 X 1010 1.40 X 1010 8.40 X 109 1.27 X 1010 1.00 
RK1276(∆nusA) 1.68 X 109 1.44 X 109 1.72 X 109 1.61 X 109 0.14 
RK1277(∆nusG) 6.80 X 109 6.00 X 109 7.60 X 109 6.80 X 109 0.59 
RK1278(∆rac) 2.48 X 1010 2.12 X 1010 3.16 X 1010 2.59 X 1010 1.66 
RK1279(∆rac, ∆nusG) 1.92 X 1010 1.12 X 1010 1.00 X 1010 1.35 X 1010 1.07 
RK898 2.92 X 1010 1.08 X 1010 1.44 X 1010 1.81 X 1010 1.00 
RK899(rpcCY75N) No growth No growth No growth N/A ≤10-7 
*EOP values are an average of three trials 
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Generating deletions in the left operon of HK639 prophage 
Upon deletion of the PL promoter, HK022 continues to grow lytically (56). 
Antitermination sites, located in each early operon, control the expression of HK022 
early genes. HK639 has an antitermination site in its left operon but it is unknown 
whether the expression of the left operon is essential to its growth. A map of the left 
operon of HK639 is shown in Figure 7.                                                                                                                       
To determine if genes located in the left operon of HK639 are essential to lytic 
growth, recombineering was used to make systematic deletions in the left operon of an 
integrated prophage; strain RK1145. The kanamycin resistance gene (kanR), amplified 
from strain RK1097, was used to replace defined segments of the HK639 left operon.   
Primers RK654 and RK655 were used to generate the recombineering substrate 
by PCR.  Recombination with this substrate resulted in the replacement of the HK639 PL 
and putL sequences and the recombinants were selected for kanamycin resistance. The 
resulting strain, designated RK1288(∆PL-putL::kanR), was verified using primer sets 
RK659 x RK291 and RK232 x RK290 to amplify the recombinant DNA junctions 
(Figure 8). These PCR products were sequenced to confirm that each junction was 
generated as designed.  
 
 
 
 
 
 
  
 
 
Figure 7. Map of HK639 
black arrow. The putL antitermination sequence is labeled in blue. Predicted intrinsic 
transcription terminators are identified with red 
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left operon. The left operon promoter, PL, is indicated with a 
arrows 
  
 
 
   
Figure 8. Creating the PL-
recombineering substrate. Lane 1 
amplified with primer set RK654 x RK655. The expecte
Verification of the recombination junctions. Lane 1 
junction, amplified with primer set RK659 x RK 291
upstream junction, amplified with primer set RK232 x RK290
Map of strain RK1288(∆P
(green arrow). Primers used for recombineering and junction verification are marked with 
tan arrows. Predicted intrinsic transcription terminators are identified with red arrows.
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To replace the putL sequence only, Primers RK706 and RK707 were used to 
generate a recombineering substrate by PCR. The resulting strain, designated 
RK1319(∆putL::kanR), was verified using primer sets RK227 x RK291 and RK277 x 
RK290 to amplify the recombinant DNA junctions. These PCR products were sequenced 
to confirm that each junction was generated as designed.  The results of this analysis are 
shown in Figure 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 9. Creating the put
recombineering substrate
amplified with primer set RK706 x RK707
recombination junctions. Lane 1 
amplified with primer set RK227 x RK 291
junction, amplified with primer set RK277 and RK290
of strain RK1319(∆putL::
arrow). Primers used for recombineering and junction verification are marked with tan 
arrows. Predicted intrinsic transcription terminators are 
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 The next deletion in the series replaced base pairs 30,880-33,048 of HK639 with 
the kanamycin resistance gene. Primers RK728 and RK729 were used to generate the 
recombineering substrate by PCR (Figure 10). The resulting strain, designated RK1328, 
was verified using primer sets RK734 x RK291 and RK570 x RK290 to amplify the 
recombinant DNA junctions (Figure 11). The PCR products were sequenced to confirm 
that each junction was generated as designed.  A map of strain RK1328 is shown in 
Figure 12.  
To replace base pairs 29,152-30,887 of HK639 with the kanamycin resistance 
gene, primers RK730 and RK731 were used to generate the recombineering substrate by 
PCR (Figure 10). The resulting strain, designated RK1329, was verified using primer sets 
RK735 x RK291 and RK736 x RK290 to amplify the recombinant DNA junctions 
(Figure 11). The PCR products were sequenced to confirm that each junction was 
generated as designed. A map of strain RK1329 is shown in Figure 12. 
To replace base pairs 27,406-29,151 of HK639 with the kanamycin resistance 
gene, primers RK732 and RK733 were used to generate the recombineering substrate by 
PCR (Figure 10). The resulting strain, designated RK1330, was verified using primer sets 
RK299 x RK291 and RK737 x RK290 to amplify the recombinant DNA junctions 
(Figure 11). The PCR products were sequenced to confirm that each junction was 
generated as designed. A map of strain RK1330 is shown in Figure 12. 
To complete the deletion series, base pairs 26,022-27,406 of HK639 were 
replaced with the kanamycin resistance gene.   Primers RK726 and RK727 were used to 
generate a recombineering substrate by PCR (Figure 10). The resulting strain, designated 
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RK1332, was verified using primer sets RK742 x RK291 and RK192 x RK290 to 
amplify the recombinant DNA junctions (Figure 11). The PCR products were sequenced 
to confirm that each junction was generated as designed. A map of strain RK1332 is 
shown in Figure 12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 10. Generating the recombineering substrate
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Figure 11. Verification of the recombination junctions of 
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The effect of deletions in the left operon of HK639 prophage 
The deletions in strains RK1288(∆PL-putL::kanR), RK1319(∆putL::kanR) 
RK1328(∆30,880-33,048::kanR), strain RK1329(∆29,152-30,887::kanR), strain 
RK1330(∆27,406-29,151::kanR), and strain RK1332(∆26,022-27,406::kanR) were created 
in an HK639 prophage. Under most circumstances, prophages will remain stably 
integrated in the genome of their host.  However, at a low frequency the prophage may 
spontaneously enter the lytic cycle. Prophages can also be induced to enter the lytic cycle 
in response to signals such as DNA damage by UV light or by chemicals such as 
mitomycin C.     
We used phage release assays to determine whether or not the mutant prophages 
could enter the lytic cycle and produce viable phage particles. Evidence for active phage 
particles can be easily visualized by spotting lysates on lawns of susceptible host cells 
and looking for areas of clearing. The results of the phage release assays are shown in 
Table 5.  
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Table 5. Phage release assays 
 
 Strain  Bases/Gene(s) Replaced  Phage Release 
 
RK1288 
 
PL & putL 
 
No 
 
RK1319 
 
putL 
 
No 
 
RK1328 
 
30,880-33,084 
 
No 
 
RK1329 
 
29,152-30,887 
 
No 
 
RK1330 
 
27,406-29,151 
 
Yes 
 
RK1332  26,022-27,406  No 
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Our results show that removal of the promoter, PL, and the putL antitermination 
sequence (strain RK1288(∆PL-putL::kanR)) or putL only (strain RK1319(∆putL::kanR)) 
prevents phage release. To transition from prophage to lytically growing phage, the 
prophage must first excise itself from the host chromosome. This process requires 
excision factors, Int and Xis, which are encoded in the left operon. The removal of the 
left operon promoter (strain RK1288) was expected to prevent expression of the left 
operon completely and the result is consistent with this prediction. The putL only deletion 
(strain RK1319) retains a functional promoter. The inability to recover phage in this case 
suggests that antitermination is essential to complete expression of the left operon.   
Strains RK1328(∆30,880-33,048::kanR) and RK1329(∆29,152-30,887::kanR) also 
did not release phage. The left operon promoter in each of these strains was not altered 
and is assumed to be functional. The same is true for the antitermination sequences and 
the excision genes. This result suggests that there is a gene(s) located in the left operon of 
HK639, between 29,152bp and 33,048bp that is essential to phage growth. We do not 
have independent evidence that the excision genes are actually expressed in 
RK1328(∆30,880-33,048::kanR)  and RK1329(∆29,152-30,887::kanR). Strain 
RK1330(∆27,406-29,151::kanR) was the only mutant capable of releasing phage. This 
result shows that the deleted sequences are not essential for phage excision and growth.  
Strain RK1332(∆26,022-27,406::kanR) did not release phage. This was an 
expected result since this deletion removed the integrase and putative excisase gene. 
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Preparation of inserts for crossing left operon deletions onto lytically growing 
HK639 
It was previously shown that bacteriophage HK022 does not require left operon 
expression for lytic phage growth (56). This was discovered when a replacement of the 
HK022 left operon promoter was crossed onto a lytically growing phage. In this work, we 
have replaced the left operon promoter of HK639. However, this replacement was made 
in an HK639 prophage.  
To determine the effect of deleting PL and putL or putL only on the lytic growth 
of HK639, we attempted to cross the deletions onto an actively replicating phage.  The 
kanamycin resistance gene and approximately 72bp of flanking HK639 sequence was 
amplified from strain RK1288 using primers RK710 and RK711. Similarly, primers 
RK710 and RK738 were used to amplify the kanamycin resistance gene and 
approximately 72bp of flanking HK639 sequence from strain RK1319. Successful 
amplification of both deletion constructs was confirmed by analyzing the PCR products 
on an agarose gel (Figure 13.A). The PCR primers were designed with incorporated 
HindIII and BamHI restriction sites sequences which facilitated cloning into a similarly 
digested pBR322 vector (Figure 13.B and Figure 13.C). The Ligations were 
electroporated into MC1000 cells and kanamycin resistant transformants were selected on 
LB plates supplemented with kanamycin (20µg/ml). Plasmid DNA from candidate clones 
was purified and confirmed by sequencing the phage/plasmid junctions. Maps of the 
resulting clones are shown in Figure 14. 
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Figure 14. Maps of pRK1321 and pRK1331. 
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Crossing left operon deletions onto lytically growing HK639 
To cross the left operon deletions onto lytically growing HK639, infections of 
strains RK1321 and RK1331 with HK639 were performed. In each case, successful 
recombination would result in the transfer of the kanamycin resistance gene determinant 
from the plasmid to the lytically growing HK639 by homologous recombination. The 
upstream junction is identical for the kanR replacements in strains RK1321 and RK1331. 
Therefore, the lysates produced from these infections were analyzed by PCR using 
primer pair, RK227 and RK291 (Figure 15 and Figure 16). RK227 has homology to the 
phage genome, downstream of putL, and RK291 has homology to the kanamycin 
resistance gene.  
Strain RK1319(∆putL::kanR) was previously confirmed to have this junction and 
served as a positive control for the PCR amplifications. An HK639 wild type phage 
lysate served as the negative control. Only a recombinant should produce the desired 
signal (expected size = 500bp). No product of the expected size was seen in this negative 
control reaction (Figure 17).  
Cultures RK1321 and RK1331 were infected by mixing purified HK639 plaques 
with an aliquot of host cell suspension. To maximize phage production, the host cells 
were infected with a single plaque or multiple (2, 3 or 4) plaques.  The lysates produced 
under each of these conditions were tested for the presence of the HK639/kanR junction 
using the primer set RK227 x RK291.  
Recombinant phage were identified in each of the lysates as evidenced by the 
appearance of a band of the expected size (Figure 15 and Figure 16). For the RK1321 
lysates, the construct carrying pRK1321(∆PL-putL::kanR), the strongest signal was 
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generated from the 2 plaque uninduced lysate, designated lysate 1321 (Figure 15, Lane 
3). For the RK1331 lysates, the construct carrying pRK1331(∆putL::kanR), the strongest 
signal was  generated from the 4 plaque induced lysate, designated lysate 1331 (Figure 
16, Lane 11). We attempted to isolate recombinant phage from these lysates as outlined 
below.  
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Screening plaques for recombinant phage  
To identify lytically growing HK639(∆PL-putL::kanR) recombinants from lysate 
RK1321 and lytically growing HK639(∆putL::kanR) recombinants from lysate RK1331, 
a visual inspection of plaques was performed. Lytically growing phage can be identified 
by the appearance of clear plaques on a lawn of susceptible host cells. Dilutions (10-3 – 
10-6) of the lysates containing recombinant phage were plated with MC1000 cells. For 
lysate RK1321, the 10-3 dilution showed crowded yet distinct plaques. For lysate 
RK1331, the 10-2 dilution showed crowded yet distinct plaques. Ten individual plates of a 
10-3 dilution of lysate RK1321 and ten individual plates of a 10-2 dilution of the 1331 
lysate were prepared. These dilutions produced the highest number of independent 
plaques that could be viewed per plate. A visual inspection revealed no phenotypic 
difference in the plaques; all plaques appeared turbid. This result indicates that 
recombinants are either incapable of growing lytically or that the sample size was too 
small. 
Screening individual plaques for recombinant phages 
Since no phenotypic difference of plaques was observed, we attempted to identify 
recombinant phages by screening individual plaques by PCR. Plaques were picked 
randomly from plates made from the 10-3 dilution of lysate RK321 and the 10-2 dilution 
of lysate 1331and PCR was performed with primer set RK227 x RK291. The expected 
size of the product was 500bp. No evidence of recombinant phage was observed in any of 
the 1 plaque lysates (Figure 18). This result indicates that the recombinant phage are 
either incapable of growing lytically or that the sample size was too small to effectively 
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locate a recombinant. Another possibility is that our prediction was incorrect and the 
recombinant phage are capable of producing kanamycin resistant lysogens.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 18. Screening individual plaques for 
100bp ladder. All PCR products were amplified with primer set RK227 x RK291
expected size = 500bp. Lane 2 
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Figure 19. Screening individual plaques for 
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Recovery of Kan resistant lysogens from RK1321 and RK1331 lysates 
The surface of eight individual plaques from the RK1321 lysate and RK1331 
lysate were scraped with a sterile inoculating loop and streaked on LB plates 
supplemented with kanamycin (20 µg/ml). Following an overnight incubation at 37ºC, 
plates were observed for the presence of kanamycin resistant colonies. We also attempted 
to recover kanamycin resistant lysogens by using 10 µl aliquots of RK1321 and RK1321 
lysates to infect MC1000 cells. Infections were plated on LB plates supplemented with 
kanamycin (20 µg/ml) and incubated overnight at 37ºC. No kanamycin resistant colonies 
were observed from either assay suggesting that either recombinants are unable to form 
lysogens or that the sample size was too small and additional work is needed to identify 
the recombinants.  
BLAST analysis of essential gene candidates 
 Most of the deletions made in the early left operon of an HK639 prophage prevent 
phage release. In strain RK1328, base pairs 30,880-33,048 were replaced with the 
kanamycin resistance gene. Four open reading frames (orf43 – orf40) that were deleted in 
this construct have no known function. The fifth open reading frame deleted in this 
construct is predicted to be a phage related recombination protein. In strain, RK1329 base 
pairs 29,152-30,887 were replaced with the kanamycin resistance gene. Three open 
reading frames (orf38 – orf36) that were deleted in this construct have no known 
function. The fourth open reading frame deleted in this construct is predicted to be an 
adenine-specific methyltransferase. To determine if these open reading frames have 
homology to those with known function, we analyzed these open reading frames using 
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nucleotide and protein BLASTs (57). The results of this analysis are presented in Table 6 
and Table 7.  
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Table 6. Nucleotide BLAST results of selected HK639 open reading frames and their 
homologies to other phage or bacterial sequences   
Orf Putative Function Strain e- value 
43 None None  
42 gp38 Enterobacter cloacae subsp. cloacae ATCC 
13047 
6e-71 
 kil protein Enterobacteria phage phi80 4e-53 
41 Conserved 
hypothetical 
protein 
Enterobacter cloacae subsp. cloacae ATCC 
13047 
2e-127 
 FtsZ Inhibitor 
protein 
Enterobacter cloacae EcWSU1 8e-121 
40 Conserved 
hypothetical 
protein 
Enterobacter cloacae subsp. cloacae ATCC 
13047 
6e-71 
38 Partial 
hypothetical 
protein 
Enterobacter cloacae subsp. cloacae NCTC 9394 1e-176 
37 protein of 
unknown function 
DUF1317 
Enterobacter cloacae subsp. cloacae NCTC 9394 0.0 
 Exonuclease Escherichia coli str. K12 DH10B 1e-162 
 YqaJ viral 
recombinase 
family protein 
Enterobacteriaceae bacterium strain FGI 57 4e-52 
36 Adenine-specific 
methyltransferase 
Enterobacter cloacae subsp. cloacae ATCC 
13047 
 
9e-70 
 
 
 
 
   
66 
  
Table 7. Protein BLAST results of selected HK639 open reading frames and their 
homologies to other phage or bacterial proteins 
Orf Putative Function Strain e- value 
43 hypothetical protein 
WCE_01072 
Escherichia coli KTE5 3e-117 
 hypothetical protein 
WAW_01996 
Escherichia coli KTE7 2e-26 
42 hypothetical protein 
HMPREF9086_1352 
Enterobacter hormaechei ATCC 49162 2e-26 
41 cell division protein 
FtsZ 
Enterobacter cloacae subsp. cloacae ATCC 
13047 
1e-26 
40 conserved 
hypothetical protein 
Enterobacter cloacae subsp. cloacae ATCC 
13047 
1e-62 
38 Siphovirus Gp157 
family protein 
Pantoea ananatis PA13 2e-88 
37 hypothetical protein 
PGS1_11786 
Enterobacter cloacae subsp. cloacae GS1 3e-94 
36 hypothetical protein 
ECMP0215612_2610 
Escherichia coli MP021561.2 7e-29 
 hypothetical protein 
ECMP0215612_2610 
Escherichia coli MP021561.2 2e-27 
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DISCUSSION 
Nearly a century of research effort has been dedicated to deepening our 
understanding of bacteriophage biology and how they control their gene expression. The 
purpose of this work was to contribute to this area of study by investigating the 
requirements for transcription elongation and control of a newly discovered lambdoid 
phage. Lambdoid phage are temperate, meaning they can switch between the lytic and 
lysogenic lifestyles. They also have a characteristic gene organization. The early genes of 
lambdoid phage are organized into two divergently transcribed operons and the 
expression of all phage genes is tightly controlled. 
 Most lambdoid phage, ensure full expression of phage genes by suppressing 
transcription termination. This process, called antitermination, was originally discovered 
in λ (32). Antitermination of early gene transcription in λ is mediated by interactions 
between the N protein, encoded in the left operon of the phage, the phage nut (N-
utilization) sites, a copy of which is located in each operon, and host-encoded Nus (N 
utilization substance) factors (34). This type of persistent antitermination is said to be 
factor-dependent because readthrough of termination signals depends on the action of a 
protein factor (37).  
Bacteriophage HK022, a lambdoid phage, does not rely on a protein to promote 
antitermination. The transcripts of the phage put (polymerase utilization) sites interact 
directly with RNAP to convert it to a terminator resistant form (40). A put site is located 
in each of the early operons of HK022. This model differs from the λ model because 
antitermination occurs independently in the early operons.  
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Bacteriophage HK639, another lambdoid phage, is unique in terms of its 
requirement for antitermination. Studies have located a single intrinsic antiterminator 
mechanism in the left operon of HK639 (43). This site has been shown to suppress 
transcription termination and thus functions as an antiterminator RNA (43). In almost all 
other examples of phage with antiterminator RNA, the put sites have been identified in 
pairs, one in each early operon (43). The way HK639 controls antitermination of its right 
operon is unknown.  
In this study, we have presented evidence that host proteins that facilitate 
antitermination in most lambdoid phages are not required for HK639 growth. 
Specifically, we tested the ability of HK639 to grow on host cells that carry deletions in 
the host nusA and nusG genes. These factors were chosen because the help stabilize the 
transcription elongation complex and these strains were readily available to our lab. 
Plaque assays were performed and EOP values were calculated (See Table 4).  
The nusA deletion strain, RK1276, and nusG deletion strain, RK1277, both had 
an effect on the growth of HK639 according to their EOP values. However, NusA and 
NusG are essential to the growth of E. coli. NusA is a highly conserved transcription 
elongation factor which modulates intrinsic (58) and Rho-dependent termination (59). 
NusG enhances the transcriptional elongation rate of RNAP by suppressing 
transcriptional pausing (60) and it promotes forward translocation of RNAP (61). The 
deletion of either of these factors adversely affects the growth rate of E. coli cells (59).  
For comparison, we determined an EOP on a strain known to block HK639 
growth, strain RK899(rpoCY75N). The rpoCY75N mutant specifically blocks the 
interaction between put-like RNA antiterminators and RNAP (42). The EOP value of this 
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strain (≤10-7) serves as an example of a strong effect on phage growth. When compared 
to the rpoCY75N mutation, the nusA and nusG deletions had little effect. We conclude 
that the growth defect in the two host strains, RK1276(∆nusA) and RK1277(∆nusG) 
impacted the observed EOP.  
We also determined the EOP values from an additional set of nusG deletion 
mutants, RK1278(∆rac) (1.66) and RK1279(∆rac,∆nusG) (1.06). The removal of rac, a 
cryptic prophage from a ∆nusG mutant, restores nearly normal growth to E. coli cells. No 
effect on HK639 growth was seen for the nusG deletion mutant, RK1279(∆rac,∆nusG).  
Based on our results, we conclude that it is unlikely that NusA or NusG play a 
primary role in the growth of bacteriophage HK639. Results from additional trials would 
increase the validity of this study and testing additional Nus factor mutants (i.e. NusB, 
NusE) for their ability to affect phage growth would increase our current understanding 
of how host-encoded factors affect the growth of HK639.  
The deletion of selected sequences in the left operon was performed to increase 
our understanding of the requirements for gene expression in the left operon of HK639. 
Deleting the left operon promoter, PL, and the putL antitermination sequence (RK1288) 
prevented phage release as shown by phage release assay. This result underscores a 
caveat of making deletions in a prophage. The factors required for prophage excision, int 
and xis, are located in the left operon. The replacement of PL-putL in strain RK1288 
blocked the expression of left operon genes. Consequently, the mutated prophage is 
trapped within the host’s chromosome. The inability of strain RK1288(∆PL-putL::kanR) 
to release phage was consistent with our expectation. 
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Deleting putL (RK1319) only also prevented phage release. Since the promoter is 
still functional in this construct, our results suggest that antitermination is required for the 
full expression of the left operon. There are two sequential predicted Rho-independent 
terminators located about 1,400 base pairs downstream of the deletion site. The activity 
of these predicted Rho-independent terminators is unknown but it is unlikely that RNAP 
can readthough the predicted terminator set without an intact antitermination site. Even if 
the activity of the predicted terminator set is poor, the presence and location of Rho-
dependent terminators are unknown. These terminators are difficult to predict and cannot 
easily be identified by computer analysis. It is common for terminators to be present 
throughout the genomes of lambdoid phages. Therefore, we conclude that the putL 
antitermination sequence is likely to be essential for the complete expression of the left 
operon.  
Strains RK1328(∆30,880-33,048::kanR) and RK1329(∆29,152-30,887::kanR) also 
did not release phage. The promoter and antitermination sequences of these strains have 
not been interrupted by these deletions and are assumed to be functional. This result 
suggests that a gene(s) that is essential to phage growth, was deleted in these mutants. 
Although the gene products of int and xis were not measured directly, it is assumed that 
they are expressed in RK1328(∆30,880-33,048::kanR) and RK1329(∆ 
29,152-30,887::kanR) since neither deletion interrupted the sequences of  these 
genes.  
We have shown that strain RK1330(∆27,406-29,151::kanR) is capable of producing 
phage. The ability of this strain to produce viable phage particles shows that HK639 
tolerates the replacement of ~2000 base pairs of sequence in its left operon with the 
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kanamycin resistance and that the excision genes are expressed. Otherwise the prophage 
would be unable to excise itself and enter the lytic cycle. This evidence also supports the 
likelihood that excision genes are being expressed in RK1328(∆30,880-33,048:: kanR) 
and RK1329(∆29,152-30,887::kanR) as well. We propose that there is a non-excision 
related, essential gene(s) in the left operon of HK639 and that it has been replaced by the 
kan resistance cassette in strain RK1328(∆30,880-33,048::kanR) and/or 
RK1329(∆29,152-30,887:: kanR). Further, we conclude that no genes essential to phage 
growth are located between base pairs 27,406-29,151, the location of the replacement of 
RK1330. 
As expected, strain RK1332 (∆26,022-27,406::kanR) which removes base pairs 
26,022-27,406 of the left operon was unable to release phage. In this strain, the excision 
genes, int and xis, are replaced with the kanamycin resistance gene. This strain was 
designed to be a tool for identifying an int/xis complementation plasmid. Such a plasmid 
should restore phage release in RK1332. We intended to use it to test left operon deletion 
mutants for a defect in excision. Successful restoration of phage release would confirm 
that an interruption in the expression of the excision genes is the only effect on phage 
growth. This tool would enable us to make more definitive conclusions about essential 
genes in the left operon of HK639.   
To determine if expression of the left operon is essential to lytic growth of HK639 the 
deletions made in strains RK1288(∆PL-putL::kanR) and RK1319(∆ putL::kanR) were 
crossed onto lytically growing HK639. Lysates produced from growing HK639 on strain 
RK1321(pRK1321 +∆PL-putL:: kanR) and RK1331(pRK1331 +∆putL:: kanR), tested 
positive for the presence of recombinant phage. This was demonstrated by PCR 
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amplification of and gel electrophoresis. Primer set RK227 x RK291 was used to amplify 
the HK639/kanR junction. The appearance of a 500bp product from each lysate confirmed 
that recombinant phage was present in the lysate.  
To isolate the recombinant phage, the lysates were screened for phenotypic 
differences in plaque morphology. In addition, individual plaques were screened for the 
HK639/kanR junction by PCR analysis and gel electrophoresis. We also attempted to 
recover lysogens of the mutant phage by infecting susceptible host cells and selecting for 
kanamycin resistance. No kanamycin resistant colonies were recovered. We propose two 
possible explanations. The recombination events resulted in abortive phage and there is a 
non-excision related essential gene(s) located in the left operon of HK639. Or, the sample 
size was too small and additional work is needed to identify a lytically growing 
recombinant. The southern blotting technique, using a kanamycin resistance probe, could 
be used to streamline the process of screening for recombinant phage.   
We have identified open reading frames (orf42- orf40) and (orf38-orf36) as 
candidates for the non-excision associated, essential gene(s) of the left operon of HK639. 
We used nucleotide and protein BLAST analysis to search for putative functions for these 
gene products. None of the open reading frames analyzed shared homology to any known 
regulatory sequences. Our results suggest that the essential gene(s) of the left operon does 
not share homology or similarity in function to any known nucleotide sequence or 
protein.    
Future work 
Our results suggest that expression of the left operon of HK639 is necessary for 
phage growth. The mutations created in this work have narrowed the search to a 
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particular location within the phage genome. The next step would be to systematically 
delete the individual open reading frames that have been replaced in strains 
RK1328(∆30,880-33,048:: kanR) and RK1329(∆29,152-30,887:: kanR) to precisely locate 
the essential gene(s). Complementation assays should be performed to confirm the 
results. Each individual open reading frame that has been deleted should be cloned into 
an expression vector and introduced into its corresponding deletion mutant. Successful 
complemention would be marked by the restoration of phage release in the mutant strain.    
In conclusion, an investigation of its gene expression requirements has revealed 
that HK639 does not depend on host encoded Nus factors for its growth. Antitermination 
is necessary for expression of the left operon. There is a gene or genes located in the left 
operon of HK639 that is/are essential to phage growth. Selected deletions made in the left 
operon have identified ~3,000 base pairs of sequence, between base pairs 27,406-29,151, 
as the predicted location of the essential gene or genes. HK639 does not appear to have 
an analog to the N protein or a put like sequence in its right operon. This work provides a 
platform for further exploration of the gene expression requirements for a unique 
lambdoid phage, HK639.    
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